An Alternative Approach to Depigmentation by Soybean Extracts via Inhibition of the PAR-2 Pathway
- 1 April 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (4) , 587-595
- https://doi.org/10.1046/j.1523-1747.2001.01291.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Unraveling the Patterns of Subclinical Pheomelanin-Enriched Facial Hyperpigmentation: Effect of Depigmenting AgentsDermatology, 2000
- Cardiovascular and renal benefits of dry bean and soybean intakeThe American Journal of Clinical Nutrition, 1999
- Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptaseBiochemical Society Transactions, 1999
- The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agentThe American Journal of Clinical Nutrition, 1998
- Proteinase-activated receptors: novel mechanisms of signaling by serine proteasesAmerican Journal of Physiology-Cell Physiology, 1998
- Protease-activated receptor 3 is a second thrombin receptor in humansNature, 1997
- Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2Biochemical Journal, 1996
- Potent Thrombin Inhibitors That Probe the S1‘ Subsite: Tripeptide Transition State Analogues Based on a Heterocycle-Activated Carbonyl GroupJournal of Medicinal Chemistry, 1996
- A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.Proceedings of the National Academy of Sciences, 1992
- The Bowman‐Birk inhibitor. Trypsin‐ and chymotrypsin‐inhibitor from soybeansInternational Journal of Peptide and Protein Research, 1985